Non-coding RNA LINC00857 is predictive of poor patient survival and promotes tumor progression via cell cycle regulation in lung cancer

Lihui Wang,Yanli He,Weijun Liu,Shengbin Bai,Lei Xiao,Jie Zhang,Saravana M. Dhanasekaran,Zhuwen Wang,Shanker Kalyana-Sundaram,O. Alejandro Balbin,Sudhanshu Shukla,Yi Lu,Jules Lin,Rishindra M. Reddy,Philip W. Carrott,William R. Lynch,Andrew C. Chang,Arul M. Chinnaiyan,David G. Beer,Jian Zhang,Guoan Chen

DOI: https://doi.org/10.18632/oncotarget.7203

2016-02-05

Oncotarget

Abstract:We employed next generation RNA sequencing analysis to reveal dysregulated long non-coding RNAs (lncRNAs) in lung cancer utilizing 461 lung adenocarcinomas (LUAD) and 156 normal lung tissues from 3 separate institutions. We identified 281 lncRNAs with significant differential-expression between LUAD and normal lung tissue. LINC00857, a top deregulated lncRNAs, was overexpressed in tumors and significantly associated with poor survival in LUAD. knockdown of LINC00857 with siRNAs decreased tumor cell proliferation, colony formation, migration and invasion in vitro, as well as tumor growth in vivo. Overexpression of LINC00857 increased cancer cell proliferation, colony formation and invasion. Mechanistic analyses indicated that LINC00857 mediates tumor progression via cell cycle regulation. Our study highlights the diagnostic/prognostic potential of LINC00857 in LUAD besides delineating the functional and mechanistic aspects of its aberrant disease specific expression and potentially using as a new therapeutic target.